L&T Technology Services Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "L&T Technology Services Launches NVIDIA-Powered AI Lung Digital Twin Platform for Advanced Respiratory Diagnostics".
LTTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
L&T Technology Services (LTTS) has announced the launch of a next-generation AI-powered digital twin platform for lung diagnostics, surgical planning and respiratory care. The platform is built using NVIDIA's AI technologies, including Omniverse, TensorRT and MONAI, and converts standard CT scans into interactive 3D digital models of a patient's lungs. It is designed to help doctors visualize lung anatomy, plan bronchoscopy and biopsy procedures, and identify airways, vessels, tumors and lung lobes with greater accuracy. The announcement, made from San Jose on March 16, 2026, highlights LTTS's MedTech capabilities and partnership with NVIDIA, but does not disclose any financial numbers, deal size or revenue impact. The press release follows an earlier company announcement dated December 1, 2025.
Positive sentiment for LTTS as it strengthens the company's positioning in the high-growth AI-driven MedTech and healthcare digital twin space, but no immediate financial impact is disclosed. Investors should treat this as a strategic capability update rather than a revenue trigger.